We recently published a list of 10 Biggest Gainers of Last Week. In this article, we are going to take a look at where Teva Pharmaceuticals Industries Ltd. (NYSE:TEVA) stands against other biggest ...

Teva Pharmaceuticals’ share prices declined by 13.89 percent on Wednesday to finish at $18.54 each after announcing disappointing earnings guidance for 2025.

Alvotech and Teva Pharmaceuticals have announced the FDA's acceptance of their Biologics License Application for AVT06, a proposed biosimilar to Eylea®, aimed at treating various eye disorders ...

Teva Pharmaceuticals TEVA0.48%increase; green up pointing triangle will pay $450 million to resolve allegations that the generic drug manufacturer submitted false claims and violated a federal law ...

Teva Pharmaceuticals ’ TEVA -0.79% shares soared and Sanofi ’s SAN -1.34% stock moved higher following positive results from the latest trial of their jointly developed treatment for ...

Teva , the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its dominant position to delay competition to its ...

In order to achieve lasting impact, we have expanded a number of our access programs to go beyond the product by incorporating Health System Strengthening and Capacity Building efforts.

Teva also agreed to pay $25 million to resolve allegations it conspired with other generic drug companies to fix prices for three drugs.

The City of Baltimore has reached an $80 million settlement with Teva Pharmaceuticals over the company's role in the city's opioid crisis, officials announced Monday.

On October 10, the US Department of Justice (DOJ) announced that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. will pay $450 million to resolve two claims alleging Teva violated the ...

Home > Featured > Baltimore reaches $80M settlement with Teva Pharmaceuticals in opioid case The primary contributor to the majority of overdose deaths in Maryland involves some form of opioids.

Teva 2024 Healthy Future Report: Health System Strengthening and Capacity Building Published 06-09-25 Submitted by Teva Pharmaceutical Patient who is part of the Global Hope Program in Uganda At Teva, ...